# Trial of L-DOPA as a Treatment to Improve Vision in Albinism

> **NCT01176435** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 45 (actual)

## Conditions studied

- Albinism

## Interventions

- **DRUG:** Levodopa
- **DRUG:** Levodopa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01176435
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01176435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01176435, "Trial of L-DOPA as a Treatment to Improve Vision in Albinism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01176435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*